NCT03676972View on ClinicalTrials.gov

To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

May 9, 2019

Study Completion Date

May 9, 2019

Conditions
Urinary Tract Disease
Interventions
DEVICE

LithoVue Ureteroscope System

The LithoVue System is intended to be used to visualize organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes.

Trial Locations (3)

Unknown

The First Peking University Hospital, Beijing

The Third Peking University Hospital, Beijing

Chaoyang Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT03676972 - To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease | Biotech Hunter | Biotech Hunter